Ushbu ish iqtibos qilgan ishlar

147 ta ish

Ish: Chemopreventive and Anticancer Role of Resveratrol

In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery
Juan Carlos Lacal
Maqola19992 iqtibos
ABI
Dose-Dependency of Resveratrol in Providing Health Benefits
Subhendu Mukherjee, Jocelyn I. Dudley, Dipak K. Das
Maqola20102 iqtibos
ABI
Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities
Jessica Plati, Octavian Bucur, Roya Khosravi‐Far
Sharh maqola20082 iqtibos
ABI
Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?
Moammir Hasan Aziz, Shannon Reagan‐Shaw, Jianqiang Wu +2
Maqola20052 iqtibos
ABI
Oxidative stress in malignant melanoma and non-melanoma skin cancer
Christina S. Sander, Florian Hamm, Peter Elsner +1
Maqola20032 iqtibos
ABI
Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma
Yangyang Hu, Shengpeng Wang, Xu Wu +4
Sharh maqola20132 iqtibos
ABI
Important Role of Autophagy in Regulation of Metabolic Processes in Health, Disease and Aging
Zuzana Papáčková, Monika Cahová
Sharh maqola20142 iqtibos
ABI
Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials
Anupam Bishayee
Sharh maqola20092 iqtibos
ABI
Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
Ahmed M. Al‐Abd, Alì Mokhtar Mahmoud, Gamal A. El-Sherbiny +5
Maqola20112 iqtibos
ABI
Resveratrol and P-glycoprotein Inhibitors Enhance the Anti-Skin Cancer Effects of Ursolic Acid
Jacob J. Junco, Anna Mancha, Gunjan Malik +4
Maqola20132 iqtibos
ABI
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Thomas Walle, Faye Hsieh, Mark H. DeLegge +2
Maqola20042 iqtibos
ABI
Telomerase enzymatic component hTERT shortens long telomeres in human cells
Yun‐Ling Zheng, Fan Zhang, Bing Sun +9
Maqola20142 iqtibos
ABI
Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases—Safety, Pharmacokinetics, and Pharmacodynamics
Lynne Howells, D.P. Berry, P.J. Elliott +6
Maqola20112 iqtibos
ABI
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Victoria Brown, Ketan Patel, Maria Viskaduraki +11
Maqola20102 iqtibos
ABI
Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent
David J. Boocock, Guy Faust, Ketan Patel +9
Maqola20072 iqtibos
ABI
Reactive oxygen species in redox cancer therapy
Lingying Tong, Chia‐Chen Chuang, Shiyong Wu +1
Sharh maqola20152 iqtibos
ABI
Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
Zhipeng Zou, Juan Chen, Jun Yang +1
Sharh maqola20162 iqtibos
ABI
Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies
Xun Chen, Ning Duan, Caiguo Zhang +1
Sharh maqola20162 iqtibos
ABI
Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo
Jie Meng, Fangqin Guo, Haiyan Xu +3
Maqola20162 iqtibos
ABI
Effects of resveratrol on the proliferation, apoptosis and telomerase ability of human A431 epidermoid carcinoma cells
Xiaoxiang Zhai, JI-CUN DING, Zhiming Tang +5
Maqola20162 iqtibos
ABI
Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment
Sahdeo Prasad, Vivek R. Yadav, Bokyung Sung +3
Maqola20162 iqtibos
ABI
P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update
Xiaobo Wang, Kexin Liu
Sharh maqola20162 iqtibos
ABI
Effect of quercetin and resveratrol co-incorporated in liposomes against inflammatory/oxidative response associated with skin cancer
Carla Caddeo, Amparo Nácher, Antonio Vassallo +7
Maqola20162 iqtibos
ABI
Molecular signaling cascades involved in nonmelanoma skin carcinogenesis
Robert P. Feehan, Lisa M. Shantz
Sharh maqola20162 iqtibos
ABI
Survivin, a Promising Gene for Targeted Cancer Treatment
Fatemeh T. Shamsabadi, Mohammad Reza Akbari Eidgahi
Maqola20162 iqtibos
ABI